Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
518 INR | -1.23% | +2.72% | +57.28% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 137M | Sales 2023 | 10.52B 126M | Capitalization | 19.91B 238M |
---|---|---|---|---|---|
Net income 2022 | 607M 7.25M | Net income 2023 | -325M -3.88M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.62M | Net Debt 2023 | 7.79B 93.1M | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | 1,179 |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Limited
1 day | -0.94% | ||
1 week | +2.72% | ||
Current month | +12.80% | ||
1 month | +18.46% | ||
3 months | +56.15% | ||
6 months | +54.54% | ||
Current year | +57.28% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 21-05-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Director/Board Member | 58 | 21-09-01 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 21-09-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 518 | -1.23% | 40 334 |
24-04-18 | 524.4 | -2.97% | 1,915,749 |
24-04-16 | 540.5 | +6.55% | 985,861 |
24-04-15 | 507.2 | +0.30% | 868,340 |
24-04-12 | 505.8 | -1.23% | 434,170 |
Delayed Quote NSE India S.E., April 18, 2024 at 11:50 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- SHILPAMED Stock
- SHILPAMED Stock